TITLE

GP REGISTRAR: Osteoporosis - part two

AUTHOR(S)
Newson, Louise
PUB. DATE
February 2004
SOURCE
GP: General Practitioner;2/16/2004, p53
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Most patients taking an oral corticosteroid long term experience a fall in bone mass and bone mineral density. Longitudinal studies have shown that the most rapid rate of bone loss occurs in the first year of treatment and continues at a rate of two to three times normal on long-term therapy in older subjects. The exact dose of corticosteroid that induces significant bone loss is not yet established. The Great Britain-based National Osteoporosis Society has produced guidelines on the management of glucocorticoid-induced osteoporosis, which, where possible, are based on current clinical evidence. The most commonly used therapies are hormone replacement therapy and bisphosphonates.
ACCESSION #
12304384

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics